Economic Evaluation of Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer in the United States

Lang Y, Wu B, Liu X

Breast Cancer: Targets and Therapy 2022, 14:453-463

Published Date: 9 December 2022